IMUNON Trademark

Trademark Overview


On Monday, September 20, 2021, a trademark application was filed for IMUNON with the United States Patent and Trademark Office. The USPTO has given the IMUNON trademark a serial number of 97036154. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Tuesday, July 9, 2024. This trademark is owned by Celsion Corporation. The IMUNON trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations, namely, immunotherapies for the treatment of cancer and infectious diseases; biological preparations for the treatment of cancer and infectious diseases; vaccines; pharmaceutical preparations for the prevention and treatment of cancer; Biological preparations for the prevention and treatment of cancer; pharmaceutical and biological preparations for the treatment of immune system related diseases and disorders; therapeutic agents for promotion of cancer immunity, namely, therapeutic pharmaceuticals and vaccines for the treatment and prevention of cancer

Active chemical ingredients for use in the manufacture of pharmaceuticals; chemical, biological, and biochemical preparations for scientific purposes or general industrial manufacturing

Development of platform technology, namely, cancer immunotherapy, infectious disease, and gene therapy platforms for manufacturing therapeutics; Biological and biotechnology research; research and development in the pharmaceutical and biotechnology fields; scientific research and development with regard to the manufacture of pharmaceutical preparations; chemical and biological analysis; bioinformatics analysis, namely, DNA analysis services for scientific research purposes; Development of pharmaceutical preparations for treating cancer; scientific research services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological research in the fields of genetics, immunotherapy, vaccination, and oncology
imunon

General Information


Serial Number97036154
Word MarkIMUNON
Filing DateMonday, September 20, 2021
Status731 - SECOND EXTENSION - GRANTED
Status DateTuesday, July 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 16, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, immunotherapies for the treatment of cancer and infectious diseases; biological preparations for the treatment of cancer and infectious diseases; vaccines; pharmaceutical preparations for the prevention and treatment of cancer; Biological preparations for the prevention and treatment of cancer; pharmaceutical and biological preparations for the treatment of immune system related diseases and disorders; therapeutic agents for promotion of cancer immunity, namely, therapeutic pharmaceuticals and vaccines for the treatment and prevention of cancer
Goods and ServicesActive chemical ingredients for use in the manufacture of pharmaceuticals; chemical, biological, and biochemical preparations for scientific purposes or general industrial manufacturing
Goods and ServicesDevelopment of platform technology, namely, cancer immunotherapy, infectious disease, and gene therapy platforms for manufacturing therapeutics; Biological and biotechnology research; research and development in the pharmaceutical and biotechnology fields; scientific research and development with regard to the manufacture of pharmaceutical preparations; chemical and biological analysis; bioinformatics analysis, namely, DNA analysis services for scientific research purposes; Development of pharmaceutical preparations for treating cancer; scientific research services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological research in the fields of genetics, immunotherapy, vaccination, and oncology

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateSunday, October 24, 2021
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, October 24, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, October 24, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCelsion Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLawrenceville, NJ 08648

Party NameCelsion Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLawrenceville, NJ 08648

Trademark Events


Event DateEvent Description
Sunday, October 24, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 23, 2021NEW APPLICATION ENTERED
Wednesday, June 22, 2022ASSIGNED TO EXAMINER
Friday, July 1, 2022NON-FINAL ACTION WRITTEN
Friday, July 1, 2022NON-FINAL ACTION E-MAILED
Friday, July 1, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 28, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 28, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 29, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 11, 2023FINAL REFUSAL WRITTEN
Wednesday, January 11, 2023FINAL REFUSAL E-MAILED
Wednesday, January 11, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, April 5, 2023EXAMINERS AMENDMENT -WRITTEN
Wednesday, April 5, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, April 5, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, April 5, 2023ASSIGNED TO LIE
Wednesday, April 5, 2023EXAMINER'S AMENDMENT ENTERED
Monday, April 10, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 26, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 16, 2023PUBLISHED FOR OPPOSITION
Tuesday, May 16, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 11, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 10, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, January 10, 2024SOU EXTENSION 1 FILED
Wednesday, January 10, 2024SOU EXTENSION 1 GRANTED
Tuesday, July 9, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 9, 2024SOU EXTENSION 2 FILED
Tuesday, July 9, 2024SOU EXTENSION 2 GRANTED
Friday, January 12, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED